A Study Evaluating the Efficacy and Safety of ABP1011T Tablets in Patients With Advanced Solid Tumors
Clinical trial NCT07321574 · RECRUITING
Trial details
- NCT number
- NCT07321574
- Sponsor
- Shanghai AB PharmaTech Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-12-30
- Primary completion
- 2028-11-28
- Enrollment
- 110
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.